A 79-year-old man was given special access to an unreleased Eli Lilly obesity drug in April that was unavailable to the public.
At first, those with knowledge of the patient’s identity would not directly deny that the man was President Donald Trump, who turned 80 earlier this month.
Stat News reported Tuesday that the drug, called retatrutide, drew the interest of several top health officials, suggesting that the person who obtained it was high up the chain of command.
The post White House Cornered on Identity of Patient, 79, Given Special Weight Loss Drug appeared first on The Daily Beast
